IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer

Overview of attention for article published in Journal of Hematology & Oncology, June 2020

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 443 followers.

https://t.co/pnUpynoMVf irAEの発現頻度の違いは盲検化してるかどうかによる影響かも。

IMpower, CASPIAN, and more: exploring the optimal first-line immunotherapy for extensive-stage small cell lung cancer. https://t.co/Rg5MPZo6pH

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.